Cibc Private Wealth Group, LLC Bridge Bio Pharma, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,300 shares of BBIO stock, worth $204,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,300
Previous 1,800
83.33%
Holding current value
$204,534
Previous $49,000
132.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.15 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.02 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$822 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$772 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$575 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.19B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...